Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02900560
Title Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Translational Research in Oncology
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Los Angeles California 90095 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field